Interestingly, the inhibition of REV‐ERBs can increase the transcription of BMAL1 and enhance microglial Aβ phagocytic activity in AD animal models, which may be a strategy to clear and reduce the amyloid plaque deposition (Lee et al., 2020). This evidence concerns the gene BMAL1 and Alzheimer disease.